Gentamicin and Dermatitis exfoliative generalised - a phase IV clinical study of FDA data

Summary:

Dermatitis exfoliative generalised is reported as a side effect among people who take Gentamicin (gentamicin sulfate), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Vancomycin, and have Osteitis.

The phase IV clinical study analyzes which people have Dermatitis exfoliative generalised when taking Gentamicin. It is created by eHealthMe based on reports of 21,523 people who have side effects when taking Gentamicin from the FDA, and is updated regularly.

What is Gentamicin?

Gentamicin has active ingredients of gentamicin sulfate. It is often used in urinary tract infection. eHealthMe is studying from 21,654 Gentamicin users. Check the latest studies of Gentamicin.

What is Dermatitis exfoliative generalised?

Dermatitis exfoliative generalised (inflammatory skin disease with erythema and scaling that affects nearly the entire cutaneous surface) is found to be associated with 263 drugs and 197 conditions by eHealthMe. Check the latest studies of Dermatitis exfoliative generalised.

On Jul, 19, 2026

21,523 people reported to have side effects when taking Gentamicin.
Among them, 14 people (0.07%) have Dermatitis exfoliative generalised.

Could Gentamicin cause Dermatitis exfoliative generalised?

Among these 14 people:

How long have people been on Gentamicin when they have Dermatitis exfoliative generalised? *

What is the gender of people who have Dermatitis exfoliative generalised when taking Gentamicin? *

female: 38.46 %
male: 61.54 %

What is the age of people who have Dermatitis exfoliative generalised when taking Gentamicin? *

What are other drugs people take besides Gentamicin? *

Vancomycin: 8 people, 57.14%
Bactrim: 3 people, 21.43%
Zemplar: 1 person, 7.14%
Hydroxychloroquine Sulfate: 1 person, 7.14%
Amlodipine: 1 person, 7.14%
Benadryl: 1 person, 7.14%
Canagliflozin: 1 person, 7.14%
Carbamazepine: 1 person, 7.14%
Cefazolin: 1 person, 7.14%
Ceftriaxone: 1 person, 7.14%

What are other side effects people have besides Dermatitis exfoliative generalised? *

Eosinophilia (eosinophil count in the peripheral blood exceeds): 7 people, 50.00%
Hypotension (abnormally low blood pressure): 5 people, 35.71%
Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 5 people, 35.71%
Face Oedema (swelling of face): 5 people, 35.71%
Fever: 4 people, 28.57%
Leukocytosis (increased white blood cells): 4 people, 28.57%
General Physical Health Deterioration (weak health status): 4 people, 28.57%
Joint Pain: 4 people, 28.57%
Renal Tubular Disorder (disease of kidney tubules): 4 people, 28.57%
Skin Disorder (skin disease): 4 people, 28.57%

What are the existing conditions these people have? *

Osteitis (a general term for inflammation of bone): 5 people, 35.71%
Staphylococcal Sepsis (blood infection by an infection with staphylococcus bacteria): 3 people, 21.43%
Type 2 Diabetes: 1 person, 7.14%
Staphylococcal Infection (an infection with staphylococcus bacteria): 1 person, 7.14%
Septic Shock (shock due to blood infection): 1 person, 7.14%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 7.14%
Fever: 1 person, 7.14%
Diabetes: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Gentamicin and have Dermatitis exfoliative generalised?

- Check whether Dermatitis exfoliative generalised is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Gentamicin:

Gentamicin (21,654 reports)

Browse all side effects of Gentamicin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dermatitis exfoliative generalised:

Dermatitis exfoliative generalised (263 drugs)

Browse all the conditions that are associated with Dermatitis exfoliative generalised:

Dermatitis exfoliative generalised (197 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on gentamicin sulfate (the active ingredients of Gentamicin) and Gentamicin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.